Page last updated: 2024-08-25

alantolactone and Granulocytic Leukemia, Chronic

alantolactone has been researched along with Granulocytic Leukemia, Chronic in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chen, L; Huang, H; Li, JM; Liu, CX; Liu, W; Wei, W; Wu, YL; Yan, H; Zhao, S	1

Other Studies

1 other study(ies) available for alantolactone and Granulocytic Leukemia, Chronic

Article	Year
Alantolactone induces apoptosis in chronic myelogenous leukemia sensitive or resistant to imatinib through NF-κB inhibition and Bcr/Abl protein deletion. Apoptosis : an international journal on programmed cell death, 2013, Volume: 18, Issue:9 Topics: Animals; Apoptosis; Benzamides; Cell Line, Tumor; Cell Proliferation; Drug Resistance, Neoplasm; Fusion Proteins, bcr-abl; Gene Deletion; Humans; Imatinib Mesylate; Lactones; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Mice; NF-kappa B; Piperazines; Pyrimidines; Sesquiterpenes, Eudesmane; Signal Transduction	2013

Article

Year

Alantolactone induces apoptosis in chronic myelogenous leukemia sensitive or resistant to imatinib through NF-κB inhibition and Bcr/Abl protein deletion.

Apoptosis : an international journal on programmed cell death, 2013, Volume: 18, Issue:9

Topics: Animals; Apoptosis; Benzamides; Cell Line, Tumor; Cell Proliferation; Drug Resistance, Neoplasm; Fusion Proteins, bcr-abl; Gene Deletion; Humans; Imatinib Mesylate; Lactones; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Mice; NF-kappa B; Piperazines; Pyrimidines; Sesquiterpenes, Eudesmane; Signal Transduction

2013